hifibio-logo
  • About
  • Pipeline
  • DIS® Platform
  • Partnering
  • News
  • Join Us

News

  • About
    • Company Overview
    • Leadership
    • Scientific Advisory Board
    • Board of Directors
    • Scientific Founders
    • Contact
  • Pipeline
    • Overview
    • Overview
    • Programs
      • EMUNKITUG (HFB200301)
      • HFB200603
      • NUVUSTOTUG (HFB301001)
      • HFB200604
      • HFB3024
  • DIS® Platform
  • Partnering
  • News
  • Join Us

Latest News

Oct 30, 2025

HiFiBiO Therapeutics Announces the Appointment of Leading I&I Experts to its Scientific Advisory Board

All  Filter By:

Apr 6, 2021

HiFiBiO Therapeutics to Present Progress on Four Novel Immunotherapy Programs at AACR 2021

Mar 19, 2021

HiFiBiO and Gustave Roussy Researchers Demonstrate the Contribution of Galectin-9 (Gal-9) in Tumor Immune Escape

Lioness Magazine Interview
|
Interview
| Mar 11, 2021

HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by Lioness Magazine

PharmaBoardRoom Article
|
Article
| Mar 8, 2021

HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by PharmaBoardRoom and Genialis Podcast

Oct 27, 2020

HiFiBiO Therapeutics CEO Liang Schweizer Named one of the World’s Top Female Founders

< 1 … 8 9 10 11 12 … 18 >

oncoverity logo

© 2025 HiFiBiO Therapeutics, Inc.
All Rights Reserved.

Contact

contact@hifibio.com 237 Putnam Ave
Cambridge, MA 02139

Follow Us

Legal

Privacy Policy
Disclaimer
logo
  • About
    • Company Overview
    • Leadership
    • Scientific Advisory Board
    • Board of Directors
    • Scientific Founders
    • Contact
  • Pipeline
    • Overview
    • Overview
    • Programs
      • EMUNKITUG (HFB200301)
      • HFB200603
      • NUVUSTOTUG (HFB301001)
      • HFB200604
      • HFB3024
  • DIS® Platform
  • Partnering
  • News
  • Join Us